Global Gene Expression and Transcriptome Sequencing Market Growth (Status and Outlook) 2023-2029

Global Gene Expression and Transcriptome Sequencing Market Growth (Status and Outlook) 2023-2029

The global Gene Expression and Transcriptome Sequencing market size is projected to grow from US$ 4034.3 million in 2022 to US$ 9260.8 million in 2029; it is expected to grow at a CAGR of 12.6% from 2023 to 2029.

United States market for Gene Expression and Transcriptome Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Gene Expression and Transcriptome Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Gene Expression and Transcriptome Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Gene Expression and Transcriptome Sequencing players cover Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories and Fluidigm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Gene expression refers to the process by which information encoded in a gene is used to create functional gene products, such as proteins or non-coding RNAs. It involves the transcription of DNA into RNA and the subsequent translation of RNA into proteins. Gene expression is a fundamental process that plays a crucial role in various biological processes, including development, growth, and maintenance of tissues, as well as response to environmental stimuli.

LPI (LP Information)' newest research report, the “Gene Expression and Transcriptome Sequencing Industry Forecast” looks at past sales and reviews total world Gene Expression and Transcriptome Sequencing sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Expression and Transcriptome Sequencing sales for 2023 through 2029. With Gene Expression and Transcriptome Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Expression and Transcriptome Sequencing industry.

This Insight Report provides a comprehensive analysis of the global Gene Expression and Transcriptome Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Expression and Transcriptome Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Expression and Transcriptome Sequencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Expression and Transcriptome Sequencing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Expression and Transcriptome Sequencing.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Expression and Transcriptome Sequencing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Gene Expression
Transcriptome Sequencing

Segmentation by application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm

Please note: The report will take approximately 2 business days to prepare and deliver.